MANFREDINI, Rossella
 Distribuzione geografica
Continente #
NA - Nord America 10.279
EU - Europa 5.270
AS - Asia 1.325
SA - Sud America 20
Continente sconosciuto - Info sul continente non disponibili 16
OC - Oceania 14
AF - Africa 9
Totale 16.933
Nazione #
US - Stati Uniti d'America 10.231
GB - Regno Unito 2.100
IT - Italia 1.096
SE - Svezia 741
HK - Hong Kong 471
CN - Cina 439
DE - Germania 321
UA - Ucraina 224
FR - Francia 209
TR - Turchia 201
FI - Finlandia 171
BG - Bulgaria 116
IN - India 66
SI - Slovenia 65
BE - Belgio 45
CA - Canada 41
IE - Irlanda 32
VN - Vietnam 32
IR - Iran 27
RU - Federazione Russa 25
PL - Polonia 21
LT - Lituania 20
NL - Olanda 16
TW - Taiwan 15
JP - Giappone 14
MY - Malesia 14
EU - Europa 13
QA - Qatar 12
AU - Australia 11
CH - Svizzera 10
BR - Brasile 9
ES - Italia 9
PT - Portogallo 9
KR - Corea 8
PK - Pakistan 8
KE - Kenya 6
AT - Austria 5
LU - Lussemburgo 5
MX - Messico 5
NO - Norvegia 5
RO - Romania 5
AR - Argentina 4
CL - Cile 4
CZ - Repubblica Ceca 4
HU - Ungheria 4
SG - Singapore 4
A2 - ???statistics.table.value.countryCode.A2??? 3
DK - Danimarca 3
NZ - Nuova Zelanda 3
PH - Filippine 3
TH - Thailandia 3
BD - Bangladesh 2
BZ - Belize 2
CO - Colombia 2
GR - Grecia 2
IL - Israele 2
SA - Arabia Saudita 2
SK - Slovacchia (Repubblica Slovacca) 2
TN - Tunisia 2
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
ID - Indonesia 1
IM - Isola di Man 1
MD - Moldavia 1
MT - Malta 1
PE - Perù 1
RS - Serbia 1
ZA - Sudafrica 1
Totale 16.933
Città #
Southend 1.826
Fairfield 1.571
Chandler 1.007
Woodbridge 969
Ashburn 797
Houston 714
Seattle 604
Ann Arbor 548
Cambridge 523
Nyköping 510
Wilmington 506
Hong Kong 464
Jacksonville 429
Dearborn 394
Modena 271
Beijing 161
San Diego 159
Izmir 124
Princeton 122
Sofia 116
Helsinki 101
New York 91
Eugene 85
London 73
Fremont 72
Des Moines 62
Milan 52
Bremen 51
Shanghai 51
Bologna 45
Redwood City 44
Falls Church 43
Brussels 40
Shenzhen 36
Reggio Emilia 35
Dong Ket 31
Rome 29
Dublin 28
Sant'Ilario d'Enza 25
Boardman 24
Parma 22
Los Angeles 18
Ottawa 18
Palermo 18
Phoenix 18
Monmouth Junction 17
San Mateo 17
Florence 16
Hefei 16
Hounslow 16
Kraków 16
Norwalk 16
Toronto 16
Verona 15
Frankfurt am Main 14
Turin 14
Chiswick 13
Paris 13
Doha 12
Grafing 12
Segrate 11
Kunming 9
Nanjing 9
Ardabil 8
Auburn Hills 8
Augusta 8
Chicago 8
Hyderabad 8
Jinan 8
Marano sul Panaro 8
Indiana 7
Zurich 7
Acton 6
Bangalore 6
Ferrara 6
Fuzhou 6
Imola 6
Islington 6
Kilburn 6
Kish 6
Mountain View 6
Naples 6
Napoli 6
Perugia 6
Romainville 6
Saint Petersburg 6
Salerno 6
Sassuolo 6
Alexandria 5
Bari 5
Chongqing 5
Reggio Nell'emilia 5
Rimini 5
San Francisco 5
Abbiategrasso 4
Bergamo 4
Brescia 4
Brno 4
Dongguan 4
Edinburgh 4
Totale 13.399
Nome #
Targeted cancer exome sequencing reveals recurrent mutations in myeloproliferative neoplasms 381
Involvement of MAF/SPP1 axis in the development of bone marrow fibrosis in PMF patients 275
Deregulated expression of miR-29a-3p, miR-494-3p and miR-660-5p affects sensitivity to tyrosine kinase inhibitors in CML leukemic stem cells 254
miR-382-5p Controls Hematopoietic Stem Cell Differentiation Through the Downregulation of MXD1 253
C-Myb Restrains Megakaryopoiesis through the Hsa-MiR-486-3p-Driven Down-Regulation of C-Maf 246
Implementation of an NGS-based workflow for BRCA1 and BRCA2 mutation screening 245
c-Myb supports erythropoiesis through the transactivation of KLF1 and LMO2 expression. 243
Transcriptional profiles in melanocytes from clinically unaffected skin distinguish the neoplastic growth pattern in patients with melanoma 239
Genomic landscape of megakaryopoiesis and platelet function defects 234
Co-culture of hematopoietic stem/progenitor cells with human osteblasts favours mono/macrophage differentiation at the expense of the erythroid lineage 232
Epidemiology and clinical relevance of mutations in postpolycythemia vera and postessential thrombocythemia myelofibrosis: A study on 359 patients of the AGIMM group 225
miRNA-mRNA integrative analysis in primary myelofibrosis CD34+ cells: role of miR-155/JARID2 axis in abnormal megakaryopoiesis 223
Identification of a molecular signature predictive of sensitivity to differentiation induction in acute myeloid leukemia 221
Role of miR-34a-5p in Hematopoietic Progenitor Cells Proliferation and Fate Decision: Novel Insights into the Pathogenesis of Primary Myelofibrosis 220
Unravelling the Complexity of Inherited Retinal Dystrophies Molecular Testing: Added Value of Targeted Next-Generation Sequencing 218
miR-494-3p overexpression promotes megakaryocytopoiesis in primary myelofibrosis hematopoietic stem/progenitor cells by targeting SOCS6 217
Virally mediated MafB transduction induces the monocyte commitment of human CD34+ hematopoietic stem/progenitor cells 216
Calreticulin affects hematopoietic stem/progenitor cell fate by impacting erythroid and megakaryocytic differentiation 214
Integrative Analysis Of mRNA/miRNA Expression Profiles Identified JARID2 As a Shared Target Of Deregulated Mirnas In Primary Myelofibrosis 213
CALR mutational status identifies different disease subtypes of essential thrombocythemia showing distinct expression profiles 211
Preclinical study for treatment of hypospadias by advanced therapy medicinal products 211
The isopeptidase inhibitor 2cPE triggers proteotoxic stress and ATM activation in chronic lymphocytic leukemia cells 207
Amplicon-based Next Generation Sequencing: an effective approach to molecular diagnosis of Epidermolysis Bullosa 204
Role of TGF-β1/miR-382-5p/SOD2 axis in the induction of oxidative stress in CD34+ cells from primary myelofibrosis 202
Abnormal expression patterns of WT1-as, MEG3 and ANRIL long non-coding RNAs in CD34+ cells from patients with primary myelofibrosis and their clinical correlations 201
Amplicon-based next-generation sequencing: an effective approach for the molecular diagnosis of epidermolysis bullosa 199
c-Myb supports erythropoiesis by transactivating KLF1 and LMO2 expression 199
Purinergic signaling inhibits human acute myeloblastic leukemia cell proliferation, migration, and engraftment in immunodeficient mice 199
Requirement of the coiled-coil domains of p92(c-Fes) for nuclear localization in myeloid cells upon induction of differentiation 197
The extracellular nucleotide UTP is a potent inducer of hematopoietic stem cell migration 196
Valproic acid triggers erythro/megakaryocyte lineage decision through induction of GFI1B and MLLT3 expression 195
Eosinophils, but not neutrophils, exibit an efficient DNA repair machinary and high nucleolar activity 194
Impact of mutational status on outcomes in myelofibrosis patients treated with ruxolitinib in the COMFORT-II study 190
Calreticulin Ins5 and Del52 mutations impair unfolded protein and oxidative stress responses in K562 cells expressing CALR mutants 190
Gene expression profile of vitamin D3 treated HL60 cells shows an incomplete molecular phenotypic conversion to monocytes 189
Antisense inhibition of c-fes proto-oncogene blocks PMA-induced macrophage differentiation in HL60 and in FDC-P1/MAC-11 cells 184
Molecular profiling of CD34+ cells in idiopathic myelofibrosis identifies a set of disease-associated genes and reveals the clinical significance of Wilms' tumor gene 1 (WT1) 182
Analytic and Dynamic Secretory Profile of Patient-Derived Cytokine-Induced Killer Cells 182
A data-driven network model of primary myelofibrosis: transcriptional and post-transcriptional alterations in CD34+ cells 180
Bone marrow-derived hematopoietic cells undergo myogenic differentiation following a Pax-7 independent pathway 178
Correlation between differentiation plasticity and mRNA expression profiling of CD34+-derived CD14- and CD14+ human normal myeloid precursors 178
Impact Of Prognostically Detrimental Mutations (ASXL1, EZH2, SRSF2, IDH1/2) On Outcomes In Patients With Myelofibrosis Treated With Ruxolitinib In COMFORT-II 177
Molecular and functional analysis of the stem cell compartment of chronic myelogenous leukemia reveals the presence of a CD34- cell population with intrinsic resistance to imatinib 176
Isolation of human keratinocyte stem cells and high-throughput screening approach for their characterization 174
Bone marrow-specific loss of ABI1 induces myeloproliferative neoplasm with features resembling, human myelofibrosis 174
MicroRNA expression profile in granulocytes from primary myelofibrosis patients 171
Hepatocyte growth factor favors monocyte differentiation into regulatory interleukin (IL)-10++IL-12low/neg accessory cells with dendritic-cell features 170
Differential proteomic profile of leukemic CD34+ progenitor cells from chronic myeloid leukemia patients 170
Molecular and functional characterization of CD133+ stem/progenitor cells infused in patients with end-stage liver disease reveals their interplay with stromal liver cells 167
Mutations and prognosis in primary myelofibrosis 164
Terminal differentiation 163
Expression And Function Of Nerve Growth-Factor And Nerve Growth-Factor Receptor On Cultured Keratinocytes. 163
The kinetic status of hematopoietic stem cell subpopulations underlies a differential expression of genes involved in self-renewal, commitment, and engraftment. 163
Molecular profile of CD34+ stem/progenitor cells according to JAK2V617F mutation status in essential thrombocythemia. 160
Presence of a functional vitamin D receptor does not correlate with vitamin D3 phenotypic effects in myeloid differentiation 160
Extracellular purines promote the differentiation of human bone marrow-derived mesenchymal stem cells to the osteogenic and adipogenic lineages 157
Characterisation and discovery of novel miRNAs and moRNAs in JAK2V617F mutated SET2 cells 155
Expression of B7 costimulatory molecule in cultured human epidermal Langerhans cells is regulated at the mRNA level. 151
The number of prognostically detrimental mutations and prognosis in primary myelofibrosis: An international study of 797 patients 147
Mechanistic insight into WEB-2170-induced apoptosis in human acute myelogenous leukemia cells. the crucial role of PTEN. 146
Purinergic stimulation of human mesenchymal stem cells potentiates their chemotactic response to CXCL12 and increases the homing capacity and production of proinflammatory cytokines 140
Development of an IL-6 antagonist peptide that induces apoptosis in IL-6 dependent 7TD1 cells. 140
ANTISENSE STRATEGIES TO CHARACTERIZE THE ROLE OF GENES AND ONCOGENES INVOLVED IN MYELOID DIFFERENTIATION 138
Calreticulin mutation-specific immunostaining in myeloproliferative neoplasms: Pathogenetic insight and diagnostic value 135
A functionally active RAR alpha nuclear receptor is expressed in retinoic acid non responsive early myeloblastic cell lines 133
All-trans-retinoic acid induces simultaneously granulocytic differentiation and expression of inflammatory cytokines in HL-60 cells 131
Antiapoptotic effect of c-fes protooncogene during granulocytic differentiation 130
IDENTIFICATION OF A MOLECULAR SIGNATURE PREDICTIVE OF REFRACTORINESS IN ACUTE MYELOID LEUKEMIA 128
Wnt/CTNNB1 signal transduction pathway inhibits the expression of ZFP36 in squamous cell carcinoma, by inducing transcriptional repressors SNAI1, SLUG and TWIST 128
Physiological levels of 1 alpha, 25 di-hydroxyvitamin D3 induce the monocytic commitment of CD34+ hematopoietic progenitors 127
Monocyte Distribution Width (MDW) as novel inflammatory marker with prognostic significance in COVID-19 patients 125
Inhibition of c-fes expression by an antisense oligomer causes apoptosis oh HL60 cells induced to granulocytic differentiation 120
ROLE OF C-FES PROTOONCOGENE IN MYELOID DIFFERENTIATION 117
Antisense strategies in leukemias 117
IDENTIFICATION OF A MOLECULAR SIGNATURE PREDICTIVE OF REFRACTORINESS IN ACUTE MYELOID LEUKEMIA 115
Isolation and characterization of murine liver resident stem cell 111
AMPLICON-BASED NGS: AN EFFECTIVE APPROACH FOR THE MOLECULAR DIAGNOSIS OF EPIDERMOLYSIS BULLOSA 111
Gene expression profile correlates with molecular and clinical features in patients with myelofibrosis 108
Cultured Normal Human Keratinocytes Secrete Stem-Cell Factor And Express C-Kit Receptor 106
Gene Expression profile of Vitamin D3 treated HL60 cells shows a phenotypic but not a complete functional conversion to monocytes 104
Requirement of the coiled coil domains of p92c-Fes for nuclear translocation in myeloid cells upon induction of differentiation 101
Mutated clones driving leukemic transformation are already detectable at the single-cell level in CD34-positive cells in the chronic phase of primary myelofibrosis 100
miRNA142-3p targets Tet2 and impairs Treg differentiation and stability in models of type 1 diabetes 99
Cytokine-induced killer cells express CD39, CD38, CD203a, CD73 ectoenzymes and P1 adenosinergic receptors 98
Tie2 expressing monocytes in the spleen of patients with primary myelofibrosis 97
Silencing CD34 antigen in human hematopoietic stem cells 96
The Response to Oxidative Damage Correlates with Driver Mutations and Clinical Outcome in Patients with Myelofibrosis 93
MITOCHONDRIAL-DNA DELETION IN A PATIENT WITH PROGRESSIVE OPHTHALMOPLEGIA 90
Ratios between the abundance of messenger RNA and the corresponding protein of two growth-related genes, c-myc and vimentin, in leukemia blast cells.. 90
SOX2 Is a Univocal Marker for Human Oral Mucosa Epithelium Useful in Post-COMET Patient Characterization 90
Magnesium favors the capacity of vitamin d3 to induce the monocyte differentiation of u937 cells 85
Inhibition of ERK1/2 signaling prevents bone marrow fibrosis by reducing osteopontin plasma levels in a myelofibrosis mouse model 85
Genomic analysis of hematopoietic stem cell at the single-cell level: Optimization of cell fixation and whole genome amplification (WGA) protocol 84
Characterization of new ATM deletion associated with hereditary breast cancer 78
Increased Plasma Levels of lncRNAs LINC01268, GAS5 and MALAT1 Correlate with Negative Prognostic Factors in Myelofibrosis 73
Ivar, an interpretation‐oriented tool to manage the update and revision of variant annotation and classification 71
Automated capture-based NGS workflow: one thousand patients experience in a clinical routine framework 66
Overexpression of c-kit in a leukemic cell population carrying a trisomy 4 and its relationship with the proliferative capacity 62
BTK Inhibitors Impair Platelet-Mediated Antifungal Activity 58
Spectrum of ASXL1 mutations in primary myelofibrosis: Prognostic impact of the ASXL1 p.G646Wfs∗12 mutation 57
Totale 16.082
Categoria #
all - tutte 72.304
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 72.304


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019773 0 0 0 0 0 0 0 0 0 0 344 429
2019/20203.295 261 104 91 219 368 493 611 383 303 133 169 160
2020/20213.166 285 196 234 303 288 248 213 335 173 428 267 196
2021/20222.613 136 226 295 162 124 153 135 150 264 195 425 348
2022/20233.098 377 403 296 270 331 407 67 281 342 44 142 138
2023/20241.722 81 90 170 176 323 177 299 250 41 72 43 0
Totale 17.152